Depomed, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Depomed, Inc. - overview
Established
1995
Location
Newark, CA, US
Primary Industry
Pharmaceuticals
About
Established in 1995, based in California, US, Depomed is a pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions.
Current Investors
OrbiMed Advisors, Easton Capital Investment Group, S Squared Technology Corp
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development, Specialty Pharmaceuticals
Website
www.depomed.com
Total Amount Raised
Subscriber access only
Depomed, Inc. - timeline of key events
Depomed, Inc. - financials
| Fiscal Year Ended | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 443,200,000 | - | - | - | 106,275,000 | 111,014,000 | 156,234,000 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | 4.5% | 40.7% | - | - | - |
| EBITDA (USD) | 142,000,000 | - | - | - | (50,044,000) | 38,695,000 | 73,105,000 | - | - | - |
| Operating Income (USD) | - | - | - | - | (82,155,000) | 9,424,000 | 39,405,000 | - | - | - |
| Operating Margin | - | - | - | - | (77.3%) | 8.5% | 25.2% | - | - | - |
| % EBITDA Margin | 32.0% | - | - | - | (47.1%) | 34.9% | 46.8% | - | - | - |
| NET Income (USD) | - | - | - | - | (28,144,000) | (1,281,000) | 109,625,000 | - | - | - |
| % Net Margin | - | - | - | - | (26.5%) | (1.2%) | 70.2% | - | - | - |
Depomed, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Nautilus | - |
Displaying 1 - 1 of 1
Depomed, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.